Pharmacology & ToxicologyACS OmegaPeer-reviewed
Synthesis and pharmacological characterization of UVI3502, a novel cannabinoid receptor 1 (CB1) antagonist/inverse agonist
Iker Bengoetxea de Tena, Gorka Pereira‐Castelo, Jonatan Martínez‐Gardeazabal…·Rafael Rodríguez‐Puertas
This paper synthesizes and characterizes UVI3502, a novel CB1 receptor antagonist/inverse agonist, showing high affinity for CB1 and low affinity for CB2, with potential interactions with GPR55.
DOI 10.1021/acsomega.4c11355